Latest news – POMH-UK

  • Paper published (22 June 2022): The Prescribing Observatory for Mental Health initiated a quality improvement (QI) programme on clozapine use in UK mental health services. A paper on this topic has now been published in the Journal of Psychopharmacology: 'Prescribing clozapine in the UK: Quality improvement issues identified by clinical audit'. A link to the paper and further publications by POMH-UK can be found on our Resources page.
  • Data entry open (1 June 2022): Data entry for our new QI programme in 2022: The Use of melatonin is now open. Further information can be found on our Submit your data page.
  • Report released (31 May 2022): We are pleased to confirm that our re-audit report for Topic 19b 'Prescribing for depression in adult mental health services'  has now been released. The report is available to members of POMH-UK only and can be downloaded from the online Members' Area.
    • Webinar recording (9 March 2022): A recording of the POMH-UK event introducing our new QI programme in 2022: The Use of melatonin and an edited version of the slide-sets are available on the new POMH Members' Area. Any queries on how to access this site, please contact: POMH-UK@rcpsych.ac.uk
    • Paper published (23 February 2022): In 2020, POMH conducted a service evaluation outside of our planned QI programme in response to a (rescinded) Supply Disruption Alert (SDA) on the discontinuation of the Priadel brand of lithium. The results from this service evaluation has now been published in the BJPsych Bulletin: 'Plus ça change? Switching lithium preparations'. A link to the paper and further publications by POMH-UK can be found on our Resources page.
    Read more to receive further information regarding a career in psychiatry